Published in Managed Care Law Weekly, April 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at CardioDynamics.
Report 1: CardioDynamics (NASDAQ:CDIC), the innovator and leader of BioZ(R) impedance cardiography (ICG) technology, announced commencement of the PREVENT-HF trial, a multinational randomized controlled trial evaluating whether serial BioZ monitoring in chronic heart failure management will delay or prevent heart failure-related hospitalizations compared to standard clinical care. PREVENT- HF is the follow-on trial to the Company's PREDICT trial, which was published in June 2006 in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.